Wilke M - Search Results

1

Stimulation of salivary secretion in vivo by CFTR potentiators in Cftr+/+ and Cftr-/- mice.

Noël S, Strale PO, Dannhoffer L, Wilke M, DeJonge H, Rogier C, Mettey Y, Becq F. Noël S, et al. Among authors: wilke m. J Cyst Fibros. 2008 Mar;7(2):128-33. doi: 10.1016/j.jcf.2007.06.005. Epub 2007 Sep 4. J Cyst Fibros. 2008. PMID: 17766192 Free article.

2

Rescue of functional delF508-CFTR channels in cystic fibrosis epithelial cells by the alpha-glucosidase inhibitor miglustat.

Norez C, Noel S, Wilke M, Bijvelds M, Jorna H, Melin P, DeJonge H, Becq F. Norez C, et al. Among authors: wilke m. FEBS Lett. 2006 Apr 3;580(8):2081-6. doi: 10.1016/j.febslet.2006.03.010. Epub 2006 Mar 10. FEBS Lett. 2006. PMID: 16546175 Free article.

3

Parallel improvement of sodium and chloride transport defects by miglustat (n-butyldeoxynojyrimicin) in cystic fibrosis epithelial cells.

Noël S, Wilke M, Bot AG, De Jonge HR, Becq F. Noël S, et al. Among authors: wilke m. J Pharmacol Exp Ther. 2008 Jun;325(3):1016-23. doi: 10.1124/jpet.107.135582. Epub 2008 Feb 28. J Pharmacol Exp Ther. 2008. PMID: 18309088

4

Animal models of cystic fibrosis.

Scholte BJ, Davidson DJ, Wilke M, De Jonge HR. Scholte BJ, et al. Among authors: wilke m. J Cyst Fibros. 2004 Aug;3 Suppl 2:183-90. doi: 10.1016/j.jcf.2004.05.039. J Cyst Fibros. 2004. PMID: 15463956 Free article. Review.

5

Mouse models of cystic fibrosis: phenotypic analysis and research applications.

Wilke M, Buijs-Offerman RM, Aarbiou J, Colledge WH, Sheppard DN, Touqui L, Bot A, Jorna H, de Jonge HR, Scholte BJ. Wilke M, et al. J Cyst Fibros. 2011 Jun;10 Suppl 2:S152-71. doi: 10.1016/S1569-1993(11)60020-9. J Cyst Fibros. 2011. PMID: 21658634 Free article. Review.

6

Rescue of murine F508del CFTR activity in native intestine by low temperature and proteasome inhibitors.

Wilke M, Bot A, Jorna H, Scholte BJ, de Jonge HR. Wilke M, et al. PLoS One. 2012;7(12):e52070. doi: 10.1371/journal.pone.0052070. Epub 2012 Dec 21. PLoS One. 2012. PMID: 23284872 Free PMC article.

7

The cystic fibrosis transmembrane conductance regulator (CFTR) is expressed in maturation stage ameloblasts, odontoblasts and bone cells.

Bronckers A, Kalogeraki L, Jorna HJ, Wilke M, Bervoets TJ, Lyaruu DM, Zandieh-Doulabi B, Denbesten P, de Jonge H. Bronckers A, et al. Among authors: wilke m. Bone. 2010 Apr;46(4):1188-96. doi: 10.1016/j.bone.2009.12.002. Epub 2009 Dec 30. Bone. 2010. PMID: 20004757 Free PMC article.

8

Osteopenia in Cftr-deltaF508 mice.

Paradis J, Wilke M, Haston CK. Paradis J, et al. Among authors: wilke m. J Cyst Fibros. 2010 Jul;9(4):239-45. doi: 10.1016/j.jcf.2010.05.001. Epub 2010 May 31. J Cyst Fibros. 2010. PMID: 20570219 Free article.

9

Very mild disease phenotype of congenic CftrTgH(neoim)Hgu cystic fibrosis mice.

Tóth B, Wilke M, Stanke F, Dorsch M, Jansen S, Wedekind D, Charizopoulou N, Bot A, Burmester M, Leonhard-Marek S, de Jonge HR, Hedrich HJ, Breves G, Tümmler B. Tóth B, et al. Among authors: wilke m. BMC Genet. 2008 Apr 9;9:28. doi: 10.1186/1471-2156-9-28. BMC Genet. 2008. PMID: 18400105 Free PMC article.

10

Correction of the Delta phe508 cystic fibrosis transmembrane conductance regulator trafficking defect by the bioavailable compound glafenine.

Robert R, Carlile GW, Liao J, Balghi H, Lesimple P, Liu N, Kus B, Rotin D, Wilke M, de Jonge HR, Scholte BJ, Thomas DY, Hanrahan JW. Robert R, et al. Among authors: wilke m. Mol Pharmacol. 2010 Jun;77(6):922-30. doi: 10.1124/mol.109.062679. Epub 2010 Mar 3. Mol Pharmacol. 2010. PMID: 20200141

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

419 results

Search Page

Filters